Janus Henderson Group
JAZZ icon

Janus Henderson Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Janus Henderson Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.54M Hold
24,000
– – ﹤0.01% 989
2025
Q4 		$4.08M Sell
24,000
-1,300
-5% -$199K ﹤0.01% 1008
2025
Q3 		$3.33M Hold
25,300
– – ﹤0.01% 1087
2025
Q2 		$2.68M Hold
25,300
– – ﹤0.01% 1150
2025
Q1 		$3.11M Sell
25,300
-1,900
-7% -$248K ﹤0.01% 1066
2024
Q4 		$3.35M Hold
27,200
– – ﹤0.01% 1066
2024
Q3 		$3.03M Hold
27,200
– – ﹤0.01% 1100
2024
Q2 		$2.9M Buy
27,200
+20,920
+333% +$2.3M ﹤0.01% 1080
2024
Q1 		$756K Hold
6,280
– – ﹤0.01% 1804
2023
Q4 		$773K Sell
6,280
-49
-0.8% -$6.12K ﹤0.01% 1774
2023
Q3 		$819K Sell
6,329
-315,871
-98% -$42.1M ﹤0.01% 1658
2023
Q2 		$39.9M Sell
322,200
-360,773
-53% -$48.5M 0.02% 433
2023
Q1 		$99.9M Sell
682,973
-413,870
-38% -$61.2M 0.07% 249
2022
Q4 		$175M Sell
1,096,843
-1,380,957
-56% -$202M 0.12% 178
2022
Q3 		$330M Buy
2,477,800
+1,341,765
+118% +$204M 0.12% 176
2022
Q2 		$177M Buy
1,136,035
+55,508
+5% +$8.54M 0.12% 184
2022
Q1 		$168M Buy
1,080,527
+143,140
+15% +$20.8M 0.08% 231
2021
Q4 		$119M Buy
937,387
+30,626
+3% +$4.02M 0.05% 320
2021
Q3 		$118M Buy
906,761
+76,353
+9% +$11.5M 0.05% 334
2021
Q2 		$148M Buy
830,408
+7,007
+0.9% +$1.21M 0.06% 294
2021
Q1 		$135M Sell
823,401
-48,199
-6% -$7.93M 0.06% 302
2020
Q4 		$144M Sell
871,600
-61,798
-7% -$9.2M 0.07% 284
2020
Q3 		$133M Buy
933,398
+62,594
+7% +$7.76M 0.07% 271
2020
Q2 		$96.1M Buy
870,804
+44,819
+5% +$4.96M 0.05% 325
2020
Q1 		$82.4M Buy
825,985
+142,652
+21% +$18.4M 0.06% 325
2019
Q4 		$102M Sell
683,333
-14,184
-2% -$1.93M 0.05% 367
2019
Q3 		$89.4M Buy
697,517
+365
+0.1% +$48.9K 0.05% 404
2019
Q2 		$99.4M Buy
697,152
+8,473
+1% +$1.14M 0.05% 375
2019
Q1 		$98.4M Sell
688,679
-2,609
-0.4% -$340K 0.05% 385
2018
Q4 		$85.7M Sell
691,288
-173,595
-20% -$25.8M 0.05% 389
2018
Q3 		$145M Buy
864,883
+1,269
+0.1% +$218K 0.08% 301
2018
Q2 		$149M Sell
863,614
-64,493
-7% -$10.5M 0.08% 286
2018
Q1 		$140M Sell
928,107
-1,927
-0.2% -$283K 0.08% 280
2017
Q4 		$125M Buy
930,034
+76,114
+9% +$10.6M 0.08% 313
2017
Q3 		$125M Sell
853,920
-19,999
-2% -$3.02M 0.08% 304
2017
Q2 		$136M Buy
873,919
+866,691
+11,991% +$133M 0.09% 276
2017
Q1 		$1.05M Hold
7,228
– – 0.01% 672
2016
Q4 		$788K Buy
7,228
+800
+12% +$89.1K 0.01% 725
2016
Q3 		$781K Hold
6,428
– – 0.01% 703
2016
Q2 		$908K Hold
6,428
– – 0.01% 660
2016
Q1 		$839K Buy
+6,428
New +$800K 0.01% 684
2015
Q3 		– Sell
-6,428
Closed -$1.13M – 848
2015
Q2 		$1.13M Hold
6,428
– – 0.01% 641
2015
Q1 		$1.11M Sell
6,428
-3,460
-35% -$594K 0.01% 673
2014
Q4 		$1.62M Buy
9,888
+7,182
+265% +$1.19M 0.01% 568
2014
Q3 		$435K Buy
+2,706
New +$416K ﹤0.01% 721

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Janus Henderson Group's JAZZ Position: Q1 2026 in Review

Janus Henderson Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 24,000 shares worth $4.54M. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Janus Henderson Group first reported a position in JAZZ in Q3 2014 and has held it in 45 quarters since. The position peaked at $330M in Q3 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Janus Henderson Group held 24,000 shares of Jazz Pharmaceuticals worth $4.54M as of Q1 2026.
  • Janus Henderson Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #989 holding.
  • Janus Henderson Group first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 45 quarters since.
  • Janus Henderson Group's Jazz Pharmaceuticals position peaked at $330M in Q3 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.